TNF-antagonist etanercept induced reversible posterior leukoencephalopathy syndrome.
Kastrup
Oliver
O
Diener
Hans Christoph
HC
D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy; D001921:Brain / Q000473:pathology; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D054038:Posterior Leukoencephalopathy Syndrome / Q000139:chemically induced*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D000079424:Tumor Necrosis Factor Inhibitors
D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000079424:Tumor Necrosis Factor Inhibitors; D000068800:Etanercept